Invention Grant
- Patent Title: Glycosidase inhibitors
-
Application No.: US16078155Application Date: 2017-02-24
-
Publication No.: US10556902B2Publication Date: 2020-02-11
- Inventor: Anna Quattropani , Santosh S. Kulkarni , Awadut Gajendra Giri
- Applicant: Asceneuron SA
- Applicant Address: CH Lausanne
- Assignee: Asceneuron SA
- Current Assignee: Asceneuron SA
- Current Assignee Address: CH Lausanne
- Agency: Cooley LLP
- Agent Thomas J. Paxton; Heidi A. Erlacher
- Priority: IN201621006643 20160225
- International Application: PCT/EP2017/054280 WO 20170224
- International Announcement: WO2017/144639 WO 20170831
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D471/04 ; C07D403/12 ; C07D405/14 ; C07D401/12 ; C07D417/12 ; C07D513/04 ; C07D401/14 ; C07D405/12 ; C07D413/14
Abstract:
Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Public/Granted literature
- US20190055239A1 GLYCOSIDASE INHIBITORS Public/Granted day:2019-02-21
Information query
IPC分类:
